Literature DB >> 10579912

Function of the c-Myc oncogenic transcription factor.

C V Dang1, L M Resar, E Emison, S Kim, Q Li, J E Prescott, D Wonsey, K Zeller.   

Abstract

The c-myc gene and the expression of the c-Myc protein are frequently altered in human cancers. The c-myc gene encodes the transcription factor c-Myc, which heterodimerizes with a partner protein, termed Max, to regulate gene expression. Max also heterodimerizes with the Mad family of proteins to repress transcription, antagonize c-Myc, and promote cellular differentiation. The constitutive activation of c-myc expression is key to the genesis of many cancers, and hence the understanding of c-Myc function depends on our understanding of its target genes. In this review, we attempt to place the putative target genes of c-Myc in the context of c-Myc-mediated phenotypes. From this perspective, c-Myc emerges as an oncogenic transcription factor that integrates the cell cycle machinery with cell adhesion, cellular metabolism, and the apoptotic pathways. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10579912     DOI: 10.1006/excr.1999.4686

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  111 in total

Review 1.  Molecular biology of Barrett's adenocarcinoma.

Authors:  B P Wijnhoven; H W Tilanus; W N Dinjens
Journal:  Ann Surg       Date:  2001-03       Impact factor: 12.969

2.  In vivo interference with Skp1 function leads to genetic instability and neoplastic transformation.

Authors:  Roberto Piva; Jian Liu; Roberto Chiarle; Antonello Podda; Michele Pagano; Giorgio Inghirami
Journal:  Mol Cell Biol       Date:  2002-12       Impact factor: 4.272

3.  N-myc can functionally replace c-myc in murine development, cellular growth, and differentiation.

Authors:  B A Malynn; I M de Alboran; R C O'Hagan; R Bronson; L Davidson; R A DePinho; F W Alt
Journal:  Genes Dev       Date:  2000-06-01       Impact factor: 11.361

4.  Caveolin-1 upregulation contributes to c-Myc-induced high-grade prostatic intraepithelial neoplasia and prostate cancer.

Authors:  Guang Yang; Alexei A Goltsov; Chengzhen Ren; Shinji Kurosaka; Kohei Edamura; Richard Logothetis; Francesco J DeMayo; Patricia Troncoso; Jorge Blando; John DiGiovanni; Timothy C Thompson
Journal:  Mol Cancer Res       Date:  2011-12-05       Impact factor: 5.852

5.  Myc represses the p21(WAF1/CIP1) promoter and interacts with Sp1/Sp3.

Authors:  A L Gartel; X Ye; E Goufman; P Shianov; N Hay; F Najmabadi; A L Tyner
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-27       Impact factor: 11.205

6.  The impact of C-MYC gene expression on gastric cancer cell.

Authors:  Lin Zhang; Yanhong Hou; Hassan Ashktorab; Liucun Gao; Yanjie Xu; Kai Wu; Junshan Zhai; Lei Zhang
Journal:  Mol Cell Biochem       Date:  2010-08-25       Impact factor: 3.396

7.  C-Myc is a Nrf2-interacting protein that negatively regulates phase II genes through their electrophile responsive elements.

Authors:  Smadar Levy; Henry Jay Forman
Journal:  IUBMB Life       Date:  2010-03       Impact factor: 3.885

8.  Chromosomal location targets different MYC family gene members for oncogenic translocations.

Authors:  Monica Gostissa; Sheila Ranganath; Julia M Bianco; Frederick W Alt
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-27       Impact factor: 11.205

9.  Activation of PI3K/Akt and MAPK pathways regulates Myc-mediated transcription by phosphorylating and promoting the degradation of Mad1.

Authors:  Jidong Zhu; John Blenis; Junying Yuan
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-01       Impact factor: 11.205

Review 10.  Adaptation to hypoxia and acidosis in carcinogenesis and tumor progression.

Authors:  Jennifer S Fang; Robert D Gillies; Robert A Gatenby
Journal:  Semin Cancer Biol       Date:  2008-03-26       Impact factor: 15.707

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.